{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:17:33Z","timestamp":1792783053824,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Tel Aviv University","id":[{"id":"https:\/\/ror.org\/04mhzgx49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    PTEN Hamartoma Tumor Syndrome (PHTS) is a rare condition characterized by a complex phenotype including gastrointestinal hamartomas and increased lifetime malignancy risk. To characterize the clinical phenotype, genetic landscape, and spectrum of malignancies within a large cohort of adult PHTS carriers. A retrospective cohort study of adult patients (\u2265\u00a018 years) followed at specialized high-risk clinics who met PHTS diagnostic criteria based on either: (1) identification of a germline PTEN pathogenic\/likely pathogenic variant, or (2) fulfillment of clinical criteria according to National Comprehensive Cancer Network (NCCN) guidelines. A total of 62 individuals were included (62.9% male; median age at inclusion 39.5, IQR, 28\u201352). All fulfilled diagnostic criteria for PHTS.\n                    <jats:italic>PTEN<\/jats:italic>\n                    pathogenic or likely pathogenic variant were identified in 50 individuals (80.6%). Colonic polyps were present in 40 patients. Malignancies were reported in 61% (n = 38), most frequently breast (n=13) and thyroid (n=7). Three individuals (4.8%) had rare soft tissue tumors: one with a desmoid tumor at age 18, one with concurrent axillary osteosarcoma and bilateral chest liposarcoma, and one with a skull-base sarcoma. Macrocephaly was observed in 33.8% (n = 21), and developmental delay, including autism spectrum disorder, in 8 patients (12.9%). One case of\n                    <jats:italic>PTEN<\/jats:italic>\n                    mosaicism was identified through tumor sequencing after negative blood genetic testing. Five individuals (8%) were treated with Sirolimus. This large cohort highlights the broad clinical spectrum and substantial cancer burden in PHTS, including rare soft tissue tumors. Constitutional mosaicism should be considered when clinical suspicion persists despite negative germline testing.\n                  <\/jats:p>","DOI":"10.1007\/s10689-026-00604-w","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:48:29Z","timestamp":1789631309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The clinical and phenotypic spectrum of PTEN hamartoma tumor syndrome: a retrospective cohort study"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2414-9355","authenticated-orcid":false,"given":"Einat","family":"Ritter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aasem Abu","family":"Shtaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Kariv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Half","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Postnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Strul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Gluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lior","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ephrat","family":"Levy-Lahad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalit","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ido","family":"Laish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elez","family":"Vainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohar","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya Aharoni","family":"Golan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"issue":"3","key":"604_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.4161\/cc.8.3.7555","volume":"8","author":"VP Krymskaya","year":"2009","unstructured":"Krymskaya VP, Goncharova EA (2009) PI3K\/mTORC1 activation in hamartoma syndromes: therapeutic prospects. Cell Cycle Georget Tex 8(3):403\u2013413. https:\/\/doi.org\/10.4161\/cc.8.3.7555","journal-title":"Cell Cycle Georget Tex"},{"issue":"12","key":"604_CR2","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1038\/s41416-020-0834-6","volume":"122","author":"T Vidotto","year":"2020","unstructured":"Vidotto T, Melo CM, Castelli E, Koti M, Dos Reis RB, Squire JA (2020) Emerging role of PTEN loss in evasion of the immune response to tumours. Br J Cancer 122(12):1732\u20131743. https:\/\/doi.org\/10.1038\/s41416-020-0834-6","journal-title":"Br J Cancer"},{"issue":"21","key":"604_CR3","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1093\/jnci\/djt277","volume":"105","author":"R Pilarski","year":"2013","unstructured":"Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E (2013) Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 105(21):1607\u20131616. https:\/\/doi.org\/10.1093\/jnci\/djt277","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"604_CR4","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/s41431-020-0651-7","volume":"28","author":"M Tischkowitz","year":"2020","unstructured":"Tischkowitz M, Colas C, Pouwels S, Hoogerbrugge N (2020) PHTS Guideline Development Group, European Reference Network GENTURIS Cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome. Eur J Hum Genet 28(10):1387\u20131393. https:\/\/doi.org\/10.1038\/s41431-020-0651-7","journal-title":"Eur J Hum Genet"},{"issue":"2","key":"604_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1172\/JCI121277","volume":"129","author":"L Yehia","year":"2019","unstructured":"Yehia L, Ngeow J, Eng C (2019) PTEN-opathies: from biological insights to evidence-based precision medicine. J Clin Invest 129(2):452\u2013464. https:\/\/doi.org\/10.1172\/JCI121277","journal-title":"J Clin Invest"},{"issue":"1","key":"604_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71991-2","volume":"14","author":"M Kapa\u010dinskait\u0117","year":"2024","unstructured":"Kapa\u010dinskait\u0117 M, Stratica N, Adomaitien\u0117 I, Rascon J, Vai\u0161nyt\u0117 B (2024) A systematic review of Bannayan - Riley - Ruvalcaba syndrome. Sci Rep 14(1):21119. https:\/\/doi.org\/10.1038\/s41598-024-71991-2","journal-title":"Sci Rep"},{"issue":"7","key":"604_CR7","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3748\/wjg.v20.i7.1833","volume":"20","author":"PP Stanich","year":"2014","unstructured":"Stanich PP, Pilarski R, Rock J, Frankel WL, El-Dika S, Meyer MM (2014) Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review. World J Gastroenterol 20(7):1833\u20131838. https:\/\/doi.org\/10.3748\/wjg.v20.i7.1833","journal-title":"World J Gastroenterol"},{"issue":"13","key":"604_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133120","volume":"13","author":"DD Dragoo","year":"2021","unstructured":"Dragoo DD, Taher A, Wong VK, Elsaiey A, Consul N, Mahmoud HS et al (2021) PTEN hamartoma tumor syndrome\/Cowden syndrome: genomics, oncogenesis, and imaging review for associated lesions and malignancy. Cancers 13(13):3120. https:\/\/doi.org\/10.3390\/cancers13133120","journal-title":"Cancers"},{"issue":"12","key":"604_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2022.104632","volume":"65","author":"LAJ Hendricks","year":"2022","unstructured":"Hendricks LAJ, Hoogerbrugge N, Venselaar H, Aretz S, Spier I, Legius E et al (2022) Genotype-phenotype associations in a large PTEN hamartoma tumor syndrome (PHTS) patient cohort. Eur J Med Genet 65(12):104632. https:\/\/doi.org\/10.1016\/j.ejmg.2022.104632","journal-title":"Eur J Med Genet"},{"issue":"10","key":"604_CR10","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.6004\/jnccn.2023.0051","volume":"21","author":"MB Daly","year":"2024","unstructured":"Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z et al (2024) NCCN Guidelines\u00ae insights: genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2024. J Natl Compr Canc Netw 21(10):1000\u20131010. https:\/\/doi.org\/10.6004\/jnccn.2023.0051","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"604_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/jnci\/djac188","volume":"115","author":"LAJ Hendricks","year":"2023","unstructured":"Hendricks LAJ, Hoogerbrugge N, Mensenkamp AR, Brunet J, Lleuger-Pujol R, H\u00f8berg-Vetti H et al (2023) Cancer risks by sex and variant type in PTEN hamartoma tumor syndrome. J Natl Cancer Inst 115(1):93\u2013103. https:\/\/doi.org\/10.1093\/jnci\/djac188","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"604_CR12","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.6004\/jnccn.2015.0161","volume":"13","author":"MC Chandhanayingyong","year":"2015","unstructured":"Chandhanayingyong MC, Bernthal NM, Ungarreevittaya P, Nelson SD, Chawla SP, Singh AS (2015) Ewing sarcoma in a patient with Cowden syndrome. J Natl Compr Cancer Netw 13(11):1310\u20131314. https:\/\/doi.org\/10.6004\/jnccn.2015.0161","journal-title":"J Natl Compr Cancer Netw"},{"issue":"1","key":"604_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajhg.2010.11.013","volume":"88","author":"MH Tan","year":"2011","unstructured":"Tan MH, Mester J, Peterson C, Yang Y, Chen JL, Rybicki LA et al (2011) A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet 88(1):42\u201356. https:\/\/doi.org\/10.1016\/j.ajhg.2010.11.013","journal-title":"Am J Hum Genet"},{"issue":"1","key":"604_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-025-00847-3","volume":"9","author":"L Yehia","year":"2025","unstructured":"Yehia L, Plitt G, Tushar AM, Liu D, Joo J, Ni Y et al (2025) Extended spectrum of cancers in PTEN hamartoma tumor syndrome. NPJ Precis Oncol 9(1):61. https:\/\/doi.org\/10.1038\/s41698-025-00847-3","journal-title":"NPJ Precis Oncol"},{"key":"604_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-025-22782-5","volume":"25","author":"J Zhou","year":"1990","unstructured":"Zhou J, Xu S, Long Y, He R, Cai J, Ding N et al (1990) Global burden of soft tissue sarcomas in 204 countries and territories from 1990 to 2021: data from the global burden of disease study 2021. BMC Public Health 25:1519. https:\/\/doi.org\/10.1186\/s12889-025-22782-5","journal-title":"BMC Public Health"},{"issue":"2","key":"604_CR16","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1111\/1346-8138.14584","volume":"46","author":"N Hatta","year":"2019","unstructured":"Hatta N, Horita Y (2019) Undifferentiated pleomorphic sarcoma in a patient with Cowden syndrome after radiotherapy for breast cancer. J Dermatol 46(2):e73\u2013e75. https:\/\/doi.org\/10.1111\/1346-8138.14584","journal-title":"J Dermatol"},{"issue":"11","key":"604_CR17","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/S1470-2045(22)00561-7","volume":"23","author":"LHS Veiga","year":"2022","unstructured":"Veiga LHS, Vo JB, Curtis RE, Mille MM, Lee C, Ramin C et al (2022) Treatment-related thoracic soft tissue sarcomas in US breast cancer survivors: a retrospective cohort study. Lancet Oncol 23(11):1451\u20131464. https:\/\/doi.org\/10.1016\/S1470-2045(22)00561-7","journal-title":"Lancet Oncol"},{"issue":"8","key":"604_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11081169","volume":"11","author":"S Stefano","year":"2019","unstructured":"Stefano S, Giovanni S (2019) The PTEN tumor suppressor gene in soft tissue sarcoma. Cancers (Basel) 11(8):1169. https:\/\/doi.org\/10.3390\/cancers11081169","journal-title":"Cancers (Basel)"},{"issue":"2","key":"604_CR19","first-page":"1091","volume":"8","author":"NQ Yang","year":"2016","unstructured":"Yang NQ, Luo XJ, Zhang J, Wang GM, Guo JM (2016) Crosstalk between Meg3 and miR-1297 regulates growth of testicular germ cell tumor through PTEN\/PI3K\/AKT pathway. Am J Transl Res. 8(2):1091\u20131099","journal-title":"Am J Transl Res."},{"issue":"11","key":"604_CR20","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/sj.onc.1208368","volume":"24","author":"D Di Vizio","year":"2005","unstructured":"Di Vizio D, Cito L, Boccia A, Chieffi P, Insabato L, Pettinato G et al (2005) Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. Oncogene 24(11):1882\u20131894. https:\/\/doi.org\/10.1038\/sj.onc.1208368","journal-title":"Oncogene"},{"issue":"8","key":"604_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27788","volume":"66","author":"BP Tullius","year":"2019","unstructured":"Tullius BP, Shankar SP, Cole S, Triano V, Aradhya S, Huang EC et al (2019) Novel heterozygous mutation in the PTEN gene associated with ovarian germ cell tumor complicated by growing teratoma syndrome and overgrowth in a two-year-old female. Pediatr Blood Cancer 66(8):e27788. https:\/\/doi.org\/10.1002\/pbc.27788","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"604_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-6497-0","volume":"20","author":"K Akizuki","year":"2020","unstructured":"Akizuki K, Sekine M, Kogure Y, Kameda T, Shide K, Koya J et al (2020) TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia. BMC Cancer 20(1):5. https:\/\/doi.org\/10.1186\/s12885-019-6497-0","journal-title":"BMC Cancer"},{"issue":"12","key":"604_CR23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/gim.2013.51","volume":"15","author":"CC Pritchard","year":"2013","unstructured":"Pritchard CC, Smith C, Marushchak T, Koehler K, Holmes H, Raskind W et al (2013) A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing. Genet Med 15(12):1004\u20131007. https:\/\/doi.org\/10.1038\/gim.2013.51","journal-title":"Genet Med"},{"issue":"7","key":"604_CR24","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/ajmg.a.61166","volume":"179","author":"MM Golas","year":"2019","unstructured":"Golas MM, Auber B, Ripperger T, Pabst B, Schmidt G, Morlot M et al (2019) Looking for the hidden mutation: Bannayan-Riley-Ruvalcaba syndrome caused by constitutional and mosaic 10q23 microdeletions involving PTEN and BMPR1A. Am J Med Genet A 179(7):1383\u20131389. https:\/\/doi.org\/10.1002\/ajmg.a.61166. (PubMed PMID: 31062505)","journal-title":"Am J Med Genet A"},{"key":"604_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-023-01600-0","volume":"16","author":"M Cavaill\u00e9","year":"2023","unstructured":"Cavaill\u00e9 M, Crampon D, Achim V, Bubien V, Uhrhammer N, Privat M et al (2023) Diagnosis of PTEN mosaicism: the relevance of additional tumor DNA sequencing. A case report and review of the literature. BMC Med Genomics 16:166. https:\/\/doi.org\/10.1186\/s12920-023-01600-0","journal-title":"BMC Med Genomics"},{"issue":"6","key":"604_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28258","volume":"67","author":"A Gurunathan","year":"2020","unstructured":"Gurunathan A, Ricci K, Iacobas I, Rednam SP, Wusik K, Fei L et al (2020) Impact of vascular anomalies on the PTEN phenotype in children and young adults. Pediatr Blood Cancer 67(6):e28258. https:\/\/doi.org\/10.1002\/pbc.28258","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"604_CR27","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1634\/theoncologist.2019-0514","volume":"24","author":"T Komiya","year":"2019","unstructured":"Komiya T, Blumenthal GM, DeChowdhury R, Fioravanti S, Ballas MS, Morris J et al (2019) A pilot study of sirolimus in subjects with Cowden syndrome or other syndromes characterized by germline mutations in PTEN. Oncologist 24(12):1510-e1265. https:\/\/doi.org\/10.1634\/theoncologist.2019-0514","journal-title":"Oncologist"},{"issue":"4","key":"604_CR28","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/pr.2013.246","volume":"75","author":"GL Schmid","year":"2014","unstructured":"Schmid GL, K\u00e4ssner F, Uhlig HH, K\u00f6rner A, Kratzsch J, H\u00e4ndel N et al (2014) Sirolimus treatment of severe PTEN hamartoma tumor syndrome: case report and in vitro studies. Pediatr Res 75(4):527\u2013534. https:\/\/doi.org\/10.1038\/pr.2013.246","journal-title":"Pediatr Res"},{"issue":"8","key":"604_CR29","doi-asserted-by":"publisher","DOI":"10.14309\/ctg.0000000000000871","volume":"16","author":"PP Stanich","year":"2025","unstructured":"Stanich PP, Gofar K, Roberts ME, Hussan H (2025) Sirolimus for colon polyposis in PTEN hamartoma tumor syndrome. Clin Transl Gastroenterol 16(8):e00871. https:\/\/doi.org\/10.14309\/ctg.0000000000000871","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00604-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00604-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00604-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:48:30Z","timestamp":1789631310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00604-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["604"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00604-w","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"assertion":[{"value":"20 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"88"}}